Insta
Russian Sputnik V Covid-19 vaccine (Pic Via Sputnik V website)
The Indian Central Drugs Standard Control Organisation’s Drug Controller General (DCGI) has revealed that the Sputnik V vaccine will be tested on 100 volunteers in the country. Dr Reddy’s Laboratories will conduct these tests as part of the phase 2 trials before moving on to the next stage, Hindustan Times has reported.
Sputnik V is a human adenoviral vector vaccine that fights the novel coronavirus. It has been developed in collaboration by the Russian Direct Investment Fund (RDIF) and Gamaleya National Research Center of Epidemiology and Microbiology.
In August, it became the world’s first registered vaccine against Covid-19 after being recorded by the Ministry of Health of Russia.
“Once the pharma company would submit the safety and immunogenicity data of phase 2, it would be analysed by the expert panel and then they can proceed for the phase 3 trial,” a government official stated to Hindustan Times.
Sputnik is slated to supply 100 million doses of its potential vaccine to Dr. Reddy’s Laboratories. Ahead of that, 1400 volunteers are set to be sought for the possible phase 3 trials.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest